Genomic analysis of an Ecuadorian individual carrying an SCN5A rare variant.
SCN5A
Ancestry
Channelopathies
Ecuador
Genomic
Journal
BMC cardiovascular disorders
ISSN: 1471-2261
Titre abrégé: BMC Cardiovasc Disord
Pays: England
ID NLM: 100968539
Informations de publication
Date de publication:
27 Jul 2024
27 Jul 2024
Historique:
received:
27
03
2024
accepted:
15
07
2024
medline:
28
7
2024
pubmed:
28
7
2024
entrez:
27
7
2024
Statut:
epublish
Résumé
Ion channels, vital transmembrane protein complexes, regulate ion movement within cells. Germline variants in channel-encoding genes lead to channelopathies. The sodium channels in cardiac cells exhibit a structure of an alpha subunit and one to two beta subunits. The alpha subunit, encoded by the SCN5A gene, comprises four domains. A fifteen-year-old Ecuadorian female with atrial flutter and abnormal sinus rhythm with no familial history of cardiovascular disease underwent NGS with the TruSight Cardio kit (Illumina). A likely pathogenic SCN5A gene variant (NM_188056.2:c.2677 C > Tp. Arg893Cys) was identified, associated with arrhythmias, long QT, atrial fibrillation, and Brugada syndrome. Ancestral analysis revealed a predominant European component (43.9%), followed by Native American (35.7%) and African (20.4%) components. The participant presents atrial flutter and conduction disorders, despite lacking typical cardiovascular risk factors. The proband carries a SCN5A variant that has not been previously reported in Latin America and may be associated to her phenotype. The documented arginine-to-cysteine substitution at position 893 in the protein is crucial for various cellular functions. The subject's mixed genetic composition highlights potential genetic contributors to atrial flutter, emphasizing the need for comprehensive genetic studies, particularly in mixed populations like Ecuadorians. This case underscores the importance of genetic analysis for personalized treatment and the significance of studying diverse genetic backgrounds in understanding cardiovascular diseases.
Sections du résumé
BACKGROUND
BACKGROUND
Ion channels, vital transmembrane protein complexes, regulate ion movement within cells. Germline variants in channel-encoding genes lead to channelopathies. The sodium channels in cardiac cells exhibit a structure of an alpha subunit and one to two beta subunits. The alpha subunit, encoded by the SCN5A gene, comprises four domains.
CASE PRESENTATION
METHODS
A fifteen-year-old Ecuadorian female with atrial flutter and abnormal sinus rhythm with no familial history of cardiovascular disease underwent NGS with the TruSight Cardio kit (Illumina). A likely pathogenic SCN5A gene variant (NM_188056.2:c.2677 C > Tp. Arg893Cys) was identified, associated with arrhythmias, long QT, atrial fibrillation, and Brugada syndrome. Ancestral analysis revealed a predominant European component (43.9%), followed by Native American (35.7%) and African (20.4%) components.
CONCLUSIONS
CONCLUSIONS
The participant presents atrial flutter and conduction disorders, despite lacking typical cardiovascular risk factors. The proband carries a SCN5A variant that has not been previously reported in Latin America and may be associated to her phenotype. The documented arginine-to-cysteine substitution at position 893 in the protein is crucial for various cellular functions. The subject's mixed genetic composition highlights potential genetic contributors to atrial flutter, emphasizing the need for comprehensive genetic studies, particularly in mixed populations like Ecuadorians. This case underscores the importance of genetic analysis for personalized treatment and the significance of studying diverse genetic backgrounds in understanding cardiovascular diseases.
Identifiants
pubmed: 39068398
doi: 10.1186/s12872-024-04049-w
pii: 10.1186/s12872-024-04049-w
doi:
Substances chimiques
NAV1.5 Voltage-Gated Sodium Channel
0
SCN5A protein, human
0
Types de publication
Case Reports
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
388Informations de copyright
© 2024. The Author(s).
Références
Knupp K, Brooks-Kayal AR. Channelopathies. Swaiman’s Pediatric Neurology: principles and practice: Sixth Edition. Elsevier Inc.; 2017. pp. 405–11.
Jarzembowski JA. Channelopathies. Pathobiology of Human Disease: a dynamic encyclopedia of Disease mechanisms. Elsevier Inc.; 2014. pp. 194–94.
Kim JB, Channelopathies. Korean J Pediatr. 2014;57:1.
doi: 10.3345/kjp.2014.57.1.1
pubmed: 24578711
pmcid: 3935107
Mitchell LB. Overview of Channelopathies. MSD manual professional edition - cardiovascular disorders, https://www.msdmanuals.com/professional/cardiovascular-disorders/arrhythmogenic-cardiac-disorders/overview-of-channelopathies (2023, accessed 23 November 2023).
Grant AO. Cardiac ion channels. Circulation: Arrhythmia Electrophysiol. 2009;2:185–94.
Hernandez CM, Richards JR, Physiology, Sodium Channels. StatPearls, https://www.ncbi.nlm.nih.gov/books/NBK545257 / (2023, accessed 23 November 2023).
Jiang D, Shi H, Tonggu L, et al. Structure of the Cardiac Sodium Channel. Cell. 2020;180:122.
doi: 10.1016/j.cell.2019.11.041
pubmed: 31866066
Yu FH, Catterall WA. Overview of the voltage-gated sodium channel family. Genome Biol. 2003;4:207.
doi: 10.1186/gb-2003-4-3-207
pubmed: 12620097
pmcid: 153452
Online Mendelian Inheritance in Man OJHUBMD. MIM Number: 600163, https://www.omim.org/entry/600163 (2023, accessed 23 November 2023).
Veerman CC, Wilde AAM, Lodder EM. The cardiac sodium channel gene SCN5A and its gene product NaV1.5: role in physiology and pathophysiology. Gene. 2015;573:177.
doi: 10.1016/j.gene.2015.08.062
pubmed: 26361848
pmcid: 6636349
Li W, Yin L, Shen C, et al. SCN5A variants: Association with cardiac disorders. Front Physiol. 2018;9:409863.
doi: 10.3389/fphys.2018.01372
Wilde AAM, Amin AS. Clinical spectrum of SCN5A mutations: long QT syndrome, Brugada Syndrome, and Cardiomyopathy. JACC Clin Electrophysiol. 2018;4:569–79.
doi: 10.1016/j.jacep.2018.03.006
pubmed: 29798782
Wilde AAM, Moss AJ, Kaufman ES, et al. Clinical aspects of type 3 Long-QT syndrome: an International Multicenter Study. Circulation. 2016;134:872–82.
doi: 10.1161/CIRCULATIONAHA.116.021823
pubmed: 27566755
pmcid: 5030177
Dakkak W, Doukky R, Sick Sinus. Syndrome. StatPearls, https://www.ncbi.nlm.nih.gov/books/NBK470599 / (2023, accessed 23 November 2023).
Ludhwani D, Goyal A, Jagtap M, Ventricular Fibrillation. StatPearls, https://www.ncbi.nlm.nih.gov/books/NBK537120 / (2023, accessed 23 November 2023).
Nesheiwat Z, Goyal A, Jagtap M. Atr Fibrillation StatPearls 2023; 1–8.
Sayed M, El, Goyal A, Callahan AL, Brugada Syndrome. StatPearls, https://www.ncbi.nlm.nih.gov/books/NBK519568 / (2023, accessed 23 November 2023).
Allen C. The difference between atrial flutter and atrial fibrillation. Br Heart Foundation, https://www.bhf.org.uk/informationsupport/heart-matters-magazine/medical/ask-the-experts/atrial-flutter (2023, accessed 23 November 2023).
Ziccardi MR, Goyal A, Maani CV, Atrial Flutter. StatPearls, https://www.ncbi.nlm.nih.gov/books/NBK540985 / (2022, accessed 23 November 2023).
Invitrogen. PureLink
Illumina. TruSight
Zambrano AK, Gaviria A, Cobos-Navarrete S, et al. The three-hybrid genetic composition of an Ecuadorian population using AIMs-InDels compared with autosomes, mitochondrial DNA and Y chromosome data. Sci Rep. 2019;9:1–8.
doi: 10.1038/s41598-019-45723-w
Deica AV, Paduraru LF, Paduraru DN, et al. The SCN5A gene is a predictor of phenotype severity in Brugada Syndrome: a Comprehensive Literature Review. Med Principles Pract. 2023;32:1–8.
doi: 10.1159/000528375
Kapplinger JD, Tester DJ, Alders M, et al. An international compendium of mutations in the SCN5A-encoded cardiac sodium channel in patients referred for Brugada syndrome genetic testing. Heart Rhythm. 2010;7:33–46.
doi: 10.1016/j.hrthm.2009.09.069
pubmed: 20129283
Li W, Yin L, Shen C et al. SCN5A variants: Association with cardiac disorders. Frontiers in Physiology; 9. Epub ahead of print 9 October 2018. https://doi.org/10.3389/fphys.2018.01372 .
Rodriguez Ziccardi M, Goyal AMCV. Atrial Flutter. 2022.
Hayashi K, Tada H, Yamagishi M. The genetics of atrial fibrillation. Curr Opin Cardiol. 2017;32:10–6.
doi: 10.1097/HCO.0000000000000356
pubmed: 27861186
National Center for Biotechnology Information NL of M. ClinVar. Genomic variation as it relates to human health.
National Center for Biotechnology Information NL of M. ClinVar. Genomic Variation as It Relates to Human Health.
Yamagata K, Horie M, Aiba T, et al. Genotype-phenotype correlation of SCN5A mutation for the clinical and electrocardiographic characteristics of Probands with Brugada Syndrome: a Japanese Multicenter Registry. Circulation. 2017;135:2255–70.
doi: 10.1161/CIRCULATIONAHA.117.027983
pubmed: 28341781
Nykamp K, Anderson M, Powers M, et al. Sherloc: a comprehensive refinement of the ACMG-AMP variant classification criteria. Genet Sci. 2017;19:1105–17.
Aizawa Y, Fujisawa T, Katsumata Y et al. Sex-dependent phenotypic variability of an SCN5a mutation: Brugada syndrome and sick sinus syndrome. J Am Heart Assoc; 7. Epub ahead of print 1 September 2018. https://doi.org/10.1161/JAHA.118.009387 .
Rossenbacker T, Carroll SJ, Liu H, et al. Novel pore mutation in SCN5A manifests as a spectrum of phenotypes ranging from atrial flutter, conduction disease, and Brugada syndrome to sudden cardiac death. Heart Rhythm. 2004;1:610–5.
doi: 10.1016/j.hrthm.2004.07.001
pubmed: 15851228
De Asmundis C, Sorgente A, Brugada P. Atrial flutter in normal heart could be first manifestation of Brugada syndrome. Acta Cardiol. 2012;67:97–100.
doi: 10.1080/AC.67.1.2146571
pubmed: 22455095
Abud A, Goyeneche R, Carlessi A, et al. Posible valor pronóstico De La fibrilación Y El flutter auricular en El síndrome De Brugada. Arch Cardiol Mex. 2013;83:4–7.
pubmed: 23453344
Muggenthaler M, Behr ER. Brugada syndrome and atrial fibrillation: pathophysiology and genetics. Europace. 2011;13:913–5.
doi: 10.1093/europace/eur094
pubmed: 21454331
Monasky MM, Micaglio E, D’imperio S et al. The Mechanism of Ajmaline and Thus Brugada Syndrome: Not Only the Sodium Channel! Frontiers in Cardiovascular Medicine; 8. Epub ahead of print 1 December 2021. https://doi.org/10.3389/fcvm.2021.782596 .
Aizawa Y, Fujisawa T, Katsumata Y, et al. Sex-dependent phenotypic variability of an SCN5a mutation: Brugada syndrome and sick sinus syndrome. J Am Heart Assoc. 2018;7:1–11.
doi: 10.1161/JAHA.118.009387
Hayashi H, Sumiyoshi M, Nakazato Y, et al. Brugada syndrome and sinus node dysfunction. J Arrhythm. 2018;34:216–21.
doi: 10.1002/joa3.12046
pubmed: 29951135
pmcid: 6009769
Rohit Rai, Shakil S, Shaikh NOB. Brugada syndrome presenting as atrial flutter with sick sinus syndrome ABSTRACT. Heart India. 2017;5:17–23.
Namdar M, Rodriguez M, Brugada P. Haemochromatosis, sinus node dysfunction and Brugada syndrome – a ménage à Trois of findings in one and the same patient: coincidence or causality? Acta Cardiol. 2012;67:249–51.
doi: 10.1080/AC.67.2.2154219
pubmed: 22641986
Risgaard B. Pacemaker implantation in a patient with brugada and sick sinus syndrome. World J Cardiol. 2013;5:65.
doi: 10.4330/wjc.v5.i3.65
pubmed: 23538678
pmcid: 3610009
Shimizu N, Iwamoto M, Nakano Y et al. Long-Term electrocardiographic follow-up from childhood of an adult patient with brugada syndrome associated with sick sinus syndrome A Case Report. 2009.
Nakajima S, Makiyama T, Hanazawa K, et al. A novel SCN5A mutation demonstrating a variety of clinical phenotypes in familial sick sinus syndrome. Intern Med. 2013;52:1805–8.
doi: 10.2169/internalmedicine.52.0085
pubmed: 23955615
Letsas KP, Korantzopoulos P, Efremidis M, et al. Sinus node disease in subjects with type 1 ECG pattern of Brugada syndrome. J Cardiol. 2013;61:227–31.
doi: 10.1016/j.jjcc.2012.12.006
pubmed: 23403368
Sokalingam S, Raghunathan G, Soundrarajan N, et al. A study on the effect of surface lysine to arginine mutagenesis on protein stability and structure using green fluorescent protein. PLoS ONE. 2012;7. https://doi.org/10.1371/journal.pone.0040410 . Epub ahead of print.
Marco AC, Neves. Mark Yeager and RA. Unusual arginine formations in protein function and assembly: rings, Strings and Stacks. J Phys Chem B. 2012;116:7006–13.
doi: 10.1021/jp3009699
Park SJ, Lui BH, Cochran JR. Rational and combinatorial methods to create designer protein interfaces. Compr Biomaterials II. 2017;4:221–47.
doi: 10.1016/B978-0-12-803581-8.10152-3
Zambrano AK, Gaviria A, Cobos-Navarrete S, et al. The three-hybrid genetic composition of an Ecuadorian population using AIMs-InDels compared with autosomes, mitochondrial DNA and Y chromosome data. Sci Rep. 2019;9:9247.
doi: 10.1038/s41598-019-45723-w
pubmed: 31239502
pmcid: 6592923
Cheng J, Tester DJ, Tan BH, et al. The common African American polymorphism SCN5A-S1103Y interacts with mutation SCN5A-R680h to increase late na current. Physiol Genomics. 2011;43:461–6.
doi: 10.1152/physiolgenomics.00198.2010
pubmed: 21385947
pmcid: 3110896
Mizusawa Y, Wilde AAM. Brugada syndrome. Circ Arrhythm Electrophysiol. 2012;5:606–16.
doi: 10.1161/CIRCEP.111.964577
pubmed: 22715240
Khawaja M, Qadeer YK, Siddiqui R, et al. Brugada syndrome within Asian populations: state-of-the-art review. Cardiogenetics. 2023;13:61–74.
doi: 10.3390/cardiogenetics13020007
Vutthikraivit W, Rattanawong P, Putthapiban P, et al. Worldwide prevalence of Brugada syndrome: a systematic review and meta-analysis. Acta Cardiol Sin. 2018;34:267–77.
pubmed: 29844648
pmcid: 5968343
Patel SS, Anees SS, Ferrick KJ. Prevalence of a brugada pattern electrocardiogram in an urban population in the United States. PACE - Pacing Clin Electrophysiol. 2009;32:704–8.
doi: 10.1111/j.1540-8159.2009.02354.x
pubmed: 19545330
Musunuru K, Hershberger RE, Day SM, et al. Genetic testing for inherited Cardiovascular diseases: A Scientific Statement from the American Heart Association. Circ Genom Precis Med. 2020;13:E000067.
doi: 10.1161/HCG.0000000000000067
pubmed: 32698598
Cadena-Ullauri S, Guevara-Ramirez P, Ruiz-Pozo V et al. Case report: genomic screening for inherited cardiac conditions in Ecuadorian mestizo relatives: improving familial diagnose. Front Cardiovasc Med; 9. Epub ahead of print 2022. https://doi.org/10.3389/fcvm.2022.1037370 .
Zambrano AK, Paz-Cruz E, Cadena-Ullauri S et al. Identification of mutations on the EMD and EYA4 genes associated with Emery–Dreifuss muscular dystrophy and deafness: a case report. Front Neurol; 14. Epub ahead of print 2023. https://doi.org/10.3389/fneur.2023.1183147 .
Guevara-Ramírez P, Cadena-Ullauri S, Ibarra-Castillo R, et al. Genomic analysis of a novel pathogenic variant in the gene LMNA associated with cardiac laminopathies found in Ecuadorian siblings: a case report. Front Cardiovasc Med. 2023;10:1–6.
doi: 10.3389/fcvm.2023.1141083
Lalangui K, Rivadeneira Maya K, Sánchez-Carrillo C, et al. The spatio-temporal dynamics of infant mortality in Ecuador from 2010 to 2019. BMC Public Health. 2022;22:1–10.
doi: 10.1186/s12889-022-14242-1
Weisschuh N, Mazzola P, Zuleger T, et al. Diagnostic genome sequencing improves diagnostic yield: a prospective single-centre study in 1000 patients with inherited eye diseases. J Med Genet. 2024;0:1–10.
Kingsmore SF, Nofsinger R, Ellsworth K. Rapid genomic sequencing for genetic disease diagnosis and therapy in intensive care units: a review. Genomic Med. 2024;9:1–14.